42 Phase I study for treatment of ovarian cancer patients...

42 Phase I study for treatment of ovarian cancer patients with symptomatic ascites using the trifunctional bispecific antibody removab® (anti-CD3 X anti-EpCAM)

A. Burges, P. Wimberger, V.A. Gorbounova, H. Sommer, B. Schmalfeldt, J. Pfisterer, M. Ströhlein, M.R. Lichinitser, A.N. Makhson, R. Kimmig
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90076-0
File:
PDF, 164 KB
english, 2003
Conversion to is in progress
Conversion to is failed